亿胜生物科技（股票代码：01061）于2026年9月15日完成一笔股份回购交易。公司通过香港联交所场内回购23,000股普通股，占截至回购前公司已发行股本（不包括库藏股）约0.00407%。每股回购价格介乎2.02港元至2.045港元，合计支付约46,810港元（约4.68万港元）。
本次回购完成后，公司已发行股份总数维持在567,006,000股，其中不包括库藏股的已发行股份数为564,939,000股，库藏股数为2,067,000股。公司此前于2026年5月26日通过购回授权，可在授权额度内回购最多56,700,600股，截至目前已合计回购2,067,000股。公司表示已遵守香港联交所证券上市规则以及相关法规，并由公司董事方海洲签署公告。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.